ArticleJAMA internal medicine2015

Cancer Drugs Approved on the Basis of a Surrogate End Point and Subsequent Overall Survival: An Analysis of 5 Years of US Food and Drug Administration Approvals.

Chul Kim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.